Suchergebnisse - "Lou, Pei-Jen"

PubPharm (339)

1

Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma : A real-world study using Taiwan Head Neck Society registry database

enthalten in: Head & neck | 2024

von Lu, H. | Hsieh, M. | Wang, H. | +19

2

Margin to depth of invasion ratio as an indicator for stratifying close margins in early-stage oral squamous cell carcinoma

enthalten in: Oral oncology | 2024

von Hung, C. | Lee, T. | Chang, C. | +4

3

The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment

enthalten in: Nature communications | 2024

von Hardaker, E. | Sanseviero, E. | Karmokar, A. | +53

4

Targeting tumor O-glycosylation modulates cancer-immune-cell crosstalk and enhances anti-PD-1 immunotherapy in head and neck cancer

enthalten in: Molecular oncology | 2024

von Lin, M. | Chuang, Y. | Wu, H. | +4

5

Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma : A Nationwide Population-Based Study (THNS-2021-08)

enthalten in: Targeted oncology | 2024

von Wang, H. | Lou, P. | Yang, M. | +11

6

Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era

enthalten in: Cancer Medicine | 2024

von Ma, W. | Hong, R. | Lou, P. | +7

7

Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma : A multidisciplinary consensus in Asia-Pacific

enthalten in: Oral oncology | 2024

von Guo, Y. | Nakashima, T. | Cho, B. | +16

8

Return to work in head and neck cancer survivors : its relationship with functional, psychological, and disease-treatment factors

enthalten in: Journal of cancer survivorship : research and practice | 2023

von Tsai, P. | Wang, C. | Fang, Y. | +7

9

Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era

enthalten in: Cancer medicine | 2023

von Ma, W. | Hong, R. | Lou, P. | +7

10

Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer

enthalten in: Journal of the National Cancer Institute | 2023

von Lu, K. | Wang, H. | Tu, Y. | +4

CommentIn: J Natl Cancer Inst. 2023 Nov 8;115(11):1427-1428. - PMID 37603719

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[34]